Membrane Thickening by the Antimicrobial Peptide PGLa  by Pabst, Georg et al.
Membrane Thickening by the Antimicrobial Peptide PGLa
Georg Pabst,* Stephan L. Grage,y Sabine Danner-Pongratz,* Weiguo Jing,* Anne S. Ulrich,yz Anthony Watts,§
Karl Lohner,* and Andrea Hickel*
*Institute of Biophysics and Nanosystems Research, Austrian Academy of Sciences, Graz, Austria; yInstitute of Biological Interfaces
and zInstitute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany; and §Oxford University Biomembrane
Structure Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom
ABSTRACT Using x-ray diffraction, solid-state 2H-NMR, differential scanning calorimetry, and dilatometry, we have observed
a perturbation of saturated acyl chain phosphatidylglycerol bilayers by the antimicrobial peptide peptidyl-glycylleucine-
carboxyamide (PGLa) that is dependent on the length of the hydrocarbon chain. In the gel phase, PGLa induces a quasi-
interdigitated phase, previously reported also for other peptides, which is most pronounced for C18 phosphatidylglycerol. In the
ﬂuid phase, we found an increase of the membrane thickness and NMR order parameter for C14 and C16 phosphatidylglycerol
bilayers, though not for C18. The data is best understood in terms of a close hydrophobic match between the C18 bilayer core
and the peptide length when PGLa is inserted with its helical axis normal to the bilayer surface. The C16 acyl chains appear to
stretch to accommodate PGLa, whereas tilting within the bilayer seems to be energetically favorable for the peptide when
inserted into bilayers of C14 phosphatidylglycerol. In contrast to the commonly accepted membrane thinning effect of
antimicrobial peptides, the data demonstrate that pore formation does not necessarily relate to changes in the overall bilayer
structure.
INTRODUCTION
Naturally occurring antimicrobial peptides (AMPs) are small
amphipathic andmostly cationicmolecules that are considered
to be promising candidates to ﬁght microbial infections (1).
Although it is not known howAMPs are able to kill bacteria so
effectively, it is generally accepted that AMPs encounter the
bacterial plasma membrane at some stage. Besides the com-
mon hypothesis that AMPs affect the physical properties of the
lipid bilayers of Gram-positive and Gram-negative bacteria,
several different modes of interaction with membranes have
been proposed. These mechanisms involve the formation of
nonlamellar phases, membrane micellization, lipid segrega-
tion, or pore formation (for recent reviews see, e.g., (2,3)). The
latter mechanism has been especially strongly supported ex-
perimentally by Huang and co-workers (4,5), who believe that
it involves the concerted formation of either toroidal or barrel-
stave pores upon peptide insertion from a surface adsorbed
state above a certain AMP threshold concentration. However,
the available data imply that the mode of interaction strongly
depends on the physicochemical properties of both the lipid
bilayer and the respective AMP.
We recently demonstrated how profoundly the outcome of
experimental results can be inﬂuenced by the choice of the lipid
model system (6,7). In those studies, the humanmultifunctional
peptide LL-37, the frog-skin AMP peptidyl-glycylleucine-
carboxyamide (PGLa), and melittin from the venom of the
European honey bee were found to induce disklike micelles in
short-chain phosphatidylcholines (PC), whereas a quasi-inter-
digitated phase was formed in phosphatidylglycerol (PG) and
long-chain PC bilayers. In turn, it was conjectured that LL-37
would bind to the surface in the presence of phosphatidylserine
bilayers, whereas no interaction was observed for phosphati-
dylethanolamine bilayers. Furthermore, in binary mixtures of
these lipids, the resultingmode of interactionwas dominated by
one of the two lipids, thoughnot necessarily by the charged one,
demonstrating that net charge is not the only important pa-
rameter to be considered. These effects, and especially the
formation of either disklike micelles or quasi-interdigitated
phases, are pronounced mainly below the chain-melting tran-
sition, Tm, of the lipid bilayers. The question, however, is how,
in the case of PGLa, these effects translate into the biologically
more relevant ﬂuid phase, as our previous experiments showed
that LL-37 leads to a thinning of PC and PGmembranes (7), as
observed also in other lipid/peptide interaction studies (4,8). In
another recent study, we observed furthermore that PGLa un-
dergoes a temperature-dependent realignment in dimyristoyl
phosphatidylcholine (DMPC)/dimyristoyl phosphatidylglyc-
erol (DMPG) bilayers, from an inserted transmembrane state in
the gel phase, via a tilted-helix alignment near the lipid chain-
melting transition, to a surface-bound state at the elevated
temperatures in the ﬂuid phase (9).
This work focuses on the effects of PGLa on the gel and
ﬂuid phases of PG, the predominant lipid of Gram-positive
bacterial membranes (3), and in addition addresses the inﬂu-
ence of hydrocarbon chain length. In the relevant buffer
conditions (20mMNa-phosphate and 130mMNaCl, pH7.4),
PG bilayers are negatively charged (10). PGLa (21 amino
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acids: GMASKAGAIAGKIAKVALKAL-NH2) belongs to
the magainin family of peptides and was originally isolated
from the skin of the African clawed frog Xenopus laevis
(11,12). The peptide exhibits a broad spectrum of antimi-
crobial activity against Gram-positive and Gram-negative
bacteria, fungi, and protozoa, whereas it has minimal toxicity
toward eukaryotic cells (13,14). Previous biophysical studies
indicate that PGLa is unstructured in aqueous solution and
does not adopt a speciﬁc conformation in the presence of
uncharged lipid bilayers if the peptide is added exogenously
(15–17). However, if the peptide is codispersed from a dry
lipid/peptide ﬁlm, and there is no excess of water present in
the sample into which the cationic peptide can escape, it will
form an a-helix even in neutral phosphatidylcholine (18) and
phosphatidylethanolamine bilayers (19). This observation
indicates the important step of electrostatic attraction of the
peptide to the membrane surface, which is further supported
by the general observation of a predominantly a-helical
structure of PGLa in the presence of negatively charged bi-
layers or micelles (15–17). Discrimination between neutral
and negatively charged lipid species is further supported by
monolayer studies (20), where PGLa was found to mix with
negatively charged lipids, but to form separate islands in
zwitterionic PCmonolayers. PGLa was also reported to adopt
different orientations in the membrane depending on peptide
concentration and synergistic interactions with magainin-2,
ranging from a surface-aligned monomeric state, via tilted
dimers, to an upright inserted state (21,22).
Combining x-ray scattering, 2H-NMR spectroscopy, dif-
ferential scanning calorimetry and dilatometry, we found in
this study that PGLa assumes a surface alignment in the gel
state of PGmembranes, inducing a quasi-interdigitated phase,
as reported previously (6,7). Above the lipid chain-melting
transition, in the ﬂuid phase, the PGLa helix inserts into the
membrane above a certain threshold concentration, most
likely with a tilted angle for DMPG and parallel to the bilayer
normal for dipalmitoyl phosphatidylglycerol (DPPG) and
distearoyl phosphatidylglycerol (DSPG). This interplay be-
tween membrane and peptide properties leads to an increase
of the membrane thickness for DMPG and DPPG, whereas
DSPG bilayers remain unaffected. Thus, our study demon-
strates that contrary to what was previously accepted, peptide
pore formation is not necessarily related to membrane thin-
ning, and may lead to no detectable changes at all in mem-




DMPG,DPPG,DSPG, and their chain perdeuterated analogs, of purity.99%,
were purchased as sodium salts from Avanti Polar Lipids (Alabaster, AL) and
usedwithout further puriﬁcation. Stock solutions were prepared in chloroform/
methanol (9:1 v/v). Before and after experiments, the purity of the phospho-
lipids was checked by thin-layer chromatography, which showed only a single
spot using CHCl3/CH3OH/NH3,conc. (65:35:5 v/v) as a solvent. Ammonia,
chloroform, methanol, sodium hydrogen phosphate, and sodium dihydrogen
phosphate were all purchased in pro analysis quality from Merck (Darmstadt,
Germany).
Peptide
PGLa was synthesized as the C-terminal amide using the solid phase method
by NeoMPS (San Diego, CA). The peptide was puriﬁed to homogeneity by
reverse-phase high-performance liquid chromatography to .98%. The
crystalline powder was stored at18C and rehydrated in 20 mM potassium
phosphate buffer with 130 mM NaCl, pH 7.4, before the experiments.
Liposomes
Appropriate amounts (see below for details) of the phospholipid stock so-
lutions were dried under a stream of nitrogen and stored in vacuum overnight
to remove the organic solvent totally. The dried lipid ﬁlmswith the respective
amounts of the PGLa stock solution were dispersed by vigorous vortex-
mixing in double-distilled water containing 20 mMpotassium phosphate and
130 mM NaCl, pH 7.4. DMPG samples were then thermostated to 50C,and
DPPG and DSPG samples to 65C for 90 min, with intermittent, vigorous
vortex mixing for 1 min. After cooling to room temperature for 20 min, the
samples were used immediately for differential scanning calorimetry (DSC),
dilatometry, and x-ray measurements. For NMR measurements, the lipid
suspension was centrifuged and the concentrated lipid pellet was transferred
into the NMR sample tubes.
Differential scanning calorimetry
Calorimetric experiments were performed on a high-sensitivity VP-DSC
(Microcal, Northampton, MA). Before scanning, the samples were degassed
for 10 min and equilibrated for 30 min at low temperatures. A scan rate of
0.5C/min was used throughout. The lipid concentration was 1 mgml1. The
scans were repeated at least twice to ensure reproducibility. Data acquisition
and analysis was performed using Microcal’s Origin software. The enthalpy
change of the phase transition, DH, was obtained from the area under the
peak and the mass of phospholipid in each sample. The phase transition
temperature, Tm, was deﬁned as the temperature at the peak maximum.
Dilatometry
Similar to previous reports from our laboratory (8,23–25), the molecular lipid
volume, V, was determined from 30-mg ml1 dispersions using the DSA
5000 (Anton Paar, Graz, Austria). Themolecular volume is directly related to








where c is the lipid concentration, and r and r0 are the measured densities of
the lipid dispersion and the buffer, respectively.
Nuclear magnetic resonance spectroscopy
2H-NMR experiments were performed on perdeuterated lipid dispersions
using a Varian (Palo Alto, CA) Inova spectrometer operating at 107.4 MHz
2H resonance frequency (700 MHz for 1H), and a Bruker Avance spec-
trometer (Bruker Biospin, Karlsruhe, Germany) operating at 76.7 MHz 2H
resonance frequency (500 MHz for 1H). Deuterium NMR spectra were ac-
quired employing a quadrupolar echo experiment with a 3- to 4-ms pulse
width, 24 ms pulse spacing, and a recycle delay of 0.5 s, on a single-channel
home-built probe (107.4 MHz) or on a triple-channel Bruker probe (76.7
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MHz). The sample was equilibrated for 15–20 min at each temperature. To
extract the quadrupolar splittings, the 2H-NMR Pake doublets were decon-
voluted using a Fourier transform based ‘‘de-Paking’’ algorithm (27) im-
plemented with our own computer software.
Small- and wide-angle x-ray scattering (SWAXS)
SWAXS diffraction experiments were performed on a modiﬁed Kratky
compact camera (Hecus X-Ray Systems, Graz, Austria). Ni-ﬁltered CuKa
radiation (l¼ 1.54 A˚) originating from a sealed tube x-ray generator (Seifert,
Ahrensburg, Germany) operating at 50 kV and 40 mA was selected in
combination with a pulse-height discriminator. The x-ray beam size was 0.5
mm3 3.5 mm (V3 H). The camera was equipped with a Peltier-controlled,
programmable cuvette (temperature precision 60.1C) and linear, one-di-
mensional, position-sensitive detectors (PSD 50-M, Hecus X-Ray Systems).
Calibration of the small-angle region was performed with silver stearate, and
p-bromo-benzoic acid was used to calibrate the wide-angle region.
The lipid dispersions (50 mg ml1), were ﬁlled into thin-walled 1-mm-
thick quartz-glass capillaries, sealed, and equilibrated for 10 min at each
temperature before the x-ray diffraction experiments. Exposure times of
1800 s and 3600 s were used for the SAXS andWAXS regimes, respectively.
Background-corrected SAXS data were analyzed using the previously
described program GAP (global analysis program) (28–30), which in the
present case allowed us to retrieve the membrane thickness,
dB ¼ 2ðzH1 2sHÞ; (2)
and the hydrocarbon chain length,
dC ¼ dB=2 10 A˚; (3)
from a full q-range analysis of the SAXS patterns. The parameters zH and sH
are the position and width of the Gaussian, respectively, used to describe the
electron-dense headgroup region within the electron density model. In
combination with the molecular lipid volume determined from dilatometry,




where VC ¼ V – VH gives the volume of the hydrocarbon chains, and VH ¼
257 A˚3 (24) is the volume of the PG headgroup. Those gel-phase SAXS
patterns that show the coexistence of a quasi-interdigitated and a non-
interdigitated phase were analyzed as previously (6,7,24,31) by using a linear
combination of the scattering intensities:
IðqÞ ¼ ð1FiÞIniðqÞ1FiIiðqÞ; (5)
whereFi is the fraction of the interdigitated phase and the superscripts ‘‘ni’’
and ‘‘i’’ refer to the noninterdigitated and interdigitated phases, respectively.
RESULTS
Fig. 1 reports the DSC results of the relevant PGs at different
lipid/peptide (L/P) molar ratios. The complete thermody-
namic data is listed in Table 1, including also the DSC data on
the perdeuterated lipid analogs. Our results in the absence of
the peptide are in good agreement with previously published
data (31,32). In the case of DMPG, the enthalpy of the pre-
transition at Tp ; 10C decreased with PGLa concentration
(Fig. 1 A) and an additional phase transition peak, ;2C
higher than the original Tm, appeared at L/P ¼ 100. The
position of this peak did not shift signiﬁcantly upon the ad-
dition of further peptide, but its enthalpy increased on ac-
count of DHm. Similar ﬁndings have been reported
previously (6,33) and indicate the formation of a peptide-rich
lipid phase, which melts at a different temperature than the
pure DMPG bilayer. Both phases coexist, and their relative
amount depends on the peptide concentration. Comparable,
although more pronounced, effects were observed via DSC
for DPPG/PGLa interactions (Fig. 1 B). The pretransition had
disappeared already at L/P ¼ 50:1, and a new peak with a
phase transition temperature of 41.5C (i.e., 1.4C higher
than the Tm for pure DPPG) accounted for;40% of the total
enthalpy at L/P ¼ 100:1. Upon increasing the PGLa con-
centration to 50:1 the original main-phase transition peak of
DPPG disappeared, and at 25:1 the peak at higher tempera-
ture started to broaden, in agreement with early studies at low
FIGURE 1 Excess heat capacity curves of DMPG (A), DPPG (B), and
DSPG (C), at different PGLa concentrations. Selected cooling scans are
shown as dash-dotted lines. Numbers indicate the lipid/peptide molar ratio.
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ionic strength (17). The inﬂuence of PGLa was most pro-
nounced for DSPG (Fig. 1 C). The pretransition disappeared
at L/P ¼ 100:1, and the peak, at a temperature 0.9C higher,
was already predominant at this low PGLa concentration.
Increasing the peptide concentration further broadened the
main transition peak. The DSC studies were repeated for
perdeuterated PG analogs, where the results were comparable
to the nondeuterated lipids but shifted to lower temperatures
(Table 1).
Deuterium NMR was used to monitor the impact of PGLa
on the dynamics and structure of the surrounding lipid en-
vironment. To obtain a detailed picture of the changes in local
mobility in the hydrophobic core of the membrane, 2H-NMR
spectra of DPPG and DSPG, 2H-labeled in their acyl chains,
were measured at different temperatures and lipid/peptide
ratios. The results below the Tm are shown in Fig. 2, where in
both cases a slight change in the shoulders of the spectra was
observed upon varying L/P. A more pronounced change
occurred in the center of the lineshapes of the DPPG/PGLa
samples, as resonances with reduced splittings emerged and
ﬂattened the central Pake doublet. As this central signal
originates from the methyl groups, this observation at higher
peptide concentration suggests increased disorder at the ter-
minus of the DPPG hydrocarbon chains. In contrast, there
was no additional intensity observed in the spectra of DSPG
in the presence of peptide.
Fig. 3 shows representative 2H-NMR spectra of the DPPG
and DSPG samples in the ﬂuid phase (45C and 60C, re-
spectively), recorded at 76.7 MHz. Deuterium spectra at
107.4 MHz resulted in a similar picture, but were less well
resolved (data not shown). Pronounced changes in the
2H-NMR spectra with increasing peptide concentration were
observed in the case of DPPG (Fig. 3 A). The quadrupolar
splittings, each originating from different labeled positions
along the acyl chain, increased with an increasing amount of
PGLa. In addition to this change of the splitting sizes, a
broadening of the individual doublets and an overall change
in the lineshape was observed with increasing peptide con-
centration. Furthermore, the doublet intensities in the spec-
trum of pure DPPG are seen to increase with increasing
splitting, but they are more evenly distributed in the presence
of peptide. In contrast, for DSPG samples above Tm, no
differences in the 2H-NMR spectra were observed in the
presence and absence of PGLa (Fig. 3 B).
Because individual doublets for each 2H-labeled site were
resolved for carbon positions C7–C16 in DPPG and C7–C18 in
DSPG, respectively, we were able to analyze the 2H-NMR
spectra in the form of an order parameter proﬁle, SCD. This
allowed us to address the degree of motional averaging along
the acyl chain, and how it is affected by PGLa. The proﬁles
(Fig. 4) were determined from ‘‘de-Paked’’ spectra. In ac-
cordance with the raw data presented in Fig. 3, the overall
order of the DPPG membranes increased with increasing
peptide concentration. It is interesting to note that the varia-
tion of SCD along the acyl chain remains almost unaffected by
PGLa in the case of DPPG (Fig. 4 A). SCD changed only by an
TABLE 1 Thermodynamic data from DSC measurements of various PGs in the presence of PGLa
Lipidy L/P Tp (C) DHp (kcal/mol) Tm (C) DHm (kcal/mol) Tmyz (C) DHm (kcal/mol) DH
x
total (kcal/mol)
DMPG 10.3 0.6 22.4 7.2 7.2
DMPG 100:1 10.4 0.4 22.4 4.8 24.0 2.2 7.0
DMPG 50:1 11.6 0.1 22.7 3.1 24.5 5.1 8.2
DMPG 25:1 10.7 0.1 22.5 2.3 24.3 4.5 6.8
DMPG-d 8.9 0.6 18.8 7.2 7.2
DMPG-d 25:1 19.0 1.7 20.7 6.6 8.3
DPPG 33.3 1.5 40.2 10.8 10.8
DPPG 100:1 32.3 0.6 40.1 4.9 41.5 3.9 8.7
DPPG 50:1 41.5 9.3 9.3
DPPG 25:1 41.5 8.5 8.5
DPPG-d 27.8 35.7 9.7 9.7
DPPG-d 100:1 35.7 9.2 36.9 3.9 13.1
DPPG-d 50:1 35.7 6.8 37.0 6.2 13.0
DPPG-d 25:1 35.7 2.7 37.0 10.3 13.0
DSPG 50.4 1.0 53.6 13.0 13.0
DSPG 100:1 53.8 5.8 54.6 6.1 11.9
DSPG 50:1 54.7 11.2 11.2
DSPG 25:1 54.6 11.8 11.8
DSPG-d 48.8 14.1 14.1
DSPG-d 100:1
DSPG-d 50:1
DSPG-d 25:1 49.8 13.3 13.3
yLipid name followed by d indicates a chain-perdeuterated lipid.
zTransition temperature of the peptide-induced phase-transition peak.
§DHtotal ¼ DHm 1 DHm.
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overall constant upshift above L/P ¼ 100:1. Considering a
previous interpretation of the order parameter in terms of
chain length (34,35), the increase of SCD indicates a modest
increase in membrane thickness upon the addition of peptide.
In contrast, the presence of PGLa had no effect on the order
parameter proﬁle of DSPG (Fig. 4 B).
Finally, SWAXS experiments were performed to address
the effect of PGLa on the overall structural properties of
DMPG, DPPG, and DSPG. Fig. 5 shows the scattering pat-
terns of all three lipids in the lamellar gel phase, Lb9, at se-
lected temperatures and in the presence of PGLa (L/P ¼
25:1). The SAXS patterns of all lipids display a pure diffuse
modulation originating from positionally uncorrelated bilay-
ers as a result of electrostatic repulsion of the anionic lipids
(Fig. 5 A). A detailed analysis of the patterns in terms of a
global model (29) showed that the pure DMPG and DPPG
dispersions consist of a single phase. The DSPG sample,
however, shows a coexistence of a Lb9 and interdigitated LbI
phases, as previously reported in detail (24). A similar phase
coexistence was recently found in lysyl-DPPG bilayers (31).
The LbI phase shows up as additional diffuse scattering
around q ; 0.2 A˚1 and precludes a global data analysis in
terms of a single phase, as evidenced by the disagreement of
such a model with this scattering regime (Fig. 5 A, dash-
dotted lines). It is of interest that DPPG and DSPG bilayers
displayed a similar coexistence of interdigitated and non-
interdigitated phases in the presence of PGLa, which is again
most pronounced for DSPG. This has been reported before
also for LL-37 and melittin in PG bilayers (6,7) and can be
understood in terms of the formation of a quasi-interdigitated
phase LbIq, where the hydrophobic lipid tails are shielded by
the peptide (see Fig. 6 in Sevcsik et al. (6)). The quality of the
data presented here precludes us from detecting the LbIq
phase in the case of DMPG. The WAXS patterns, which
report on the chain lattice, are characteristic of orthorhombic
packing with tilted hydrocarbon chains for pure DMPG and
DPPG (Fig. 5 B). The WAXS pattern of pure DSPG can in
turn be described by a linear superposition of tilted hydro-
carbon chains in an orthorhombic lattice and nontilted hex-
agonally packed acyl chains (24). The occurrence of the latter
chain lattice is due to the LbI phase. The introduction of PGLa
into DMPG and DPPG bilayers led to signiﬁcant disorder, as
evidenced by the diffuse chain-packing peak in the WAXS
regime. This is in agreement with the NMR data, which
suggested increased methyl mobility in the presence of the
peptide below the Tm (see above). Also in agreement with the
NMR data (Fig. 2 B), DSPG displayed a well-deﬁnedWAXS
peak in the presence of PGLa (Fig. 5), showing nontilted
hexagonally packed chains, most likely originating from
quasi-interdigitated bilayers.
Above the chain-melting transition, in the ﬂuid lamellar La
phase, none of the sample SAXS patterns exhibited any
FIGURE 2 2H-NMR gel-phase spectra of chain-deuterated DPPG at 25C
(A) and DSPG at 40C (B), containing PGLa at different lipid/peptide ratios.
FIGURE 3 2H-NMR ﬂuid-phase spectra of chain-deuterated DPPG ves-
icles at 45C (A) and DSPG at 60C (B), containing PGLa at different
lipid:peptide ratios.
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contribution from a coexisting phase, but could all be de-
scribed in terms of a single-phase model, even in the presence
of PGLa (L/P ¼ 25:1) (Fig. 6). The ﬁts yielded x2 values
close to 1, demonstrating the signiﬁcance of the derived
structural parameters. Table 2 lists the results in the absence
and presence of PGLa and also contains the molecular vol-
ume, hydrocarbon volume, lateral area, and hydrocarbon
length of the lipids. The molecular volumes were determined
using dilatometry on liposomal dispersions. The other
structural parameters were derived as described in the pre-
vious section. The area/lipid values in the presence of PGLa
were calculated assuming that the partial molecular lipid
volume is unaffected by the peptide, in agreement with a
recent report (8). It is most interesting that both DMPG and
DPPG show an increase of the membrane thickness in the La
phase by 1–2 A˚ (Table 2). In contrast, dB remains within the
error of the measurement constant for DSPG upon the addi-
tion of the peptide. The increase of membrane thickness goes
hand in hand with a 2 A˚2 decrease of A for DMPG, and 4 A˚2
in the case of DPPG (Table 2), indicating increased lipid-
packing density in the presence of PGLa.
In Fig. 7, the calculated membrane thicknesses of the pure
PG bilayers are compared to those in the presence of PGLa
(L/P ¼ 25:1) both above and below the Tm. The general in-
crease of dB with chain length, observed for all phases, can be
attributed to the addition of CH2 groups. The coexisting
noninterdigitated phase remains unaffected, with the excep-
tion of DPPG, which displayed a slightly smaller dB value.
The reduction of the membrane thickness of DPPG could be
due to an increase in the molecular tilt angle or simply to in-
creased molecular disorder, as evidenced also in the corre-
spondingWAXS patterns (Fig. 5 B) and NMR data (Fig. 2 A).
DISCUSSION
Using DSC, 2H-NMR, and x-ray scattering, we have pro-
vided experimental evidence that PGLa interacts with PG
bilayers in a chain-length- and concentration-dependent
manner. Moreover, the effects of the peptide vary strongly
with the phase state of the lipid. Below the chain-melting
transition, PGLa induces a quasi-interdigitated phase that
coexists in various proportions with the original lamellar gel
phase. The presence of the LbIq phase was most prominent
for DSPG, which exhibits a co-existence of interdigitated and
noninterdigitated phases even in the absence of the peptide
(24). We have previously reported the occurrence of LbIq
FIGURE 5 Small- and wide-angle scattering of DMPG (i), DPPG (ii), and
DSPG (iii) in the gel phase in the absence and presence of PGLa (P/L ¼
1:25). (A) SAXS data on a logarithmic scale with an increment of 10. (B)
WAXS data on a linear scale with an increment of 1000. Solid lines show the
model ﬁts to the data in the absence of PGLa, and dashed lines to the data in
the presence of PGLa. The resulting uncertainties of the model parameters
are presented in Table 2 and Fig. 7. Dash-dotted lines correspond to ﬁts of a
single bilayer phase. Fits to the WAXS patterns were performed using a
combination of Gaussian distribution and are presented here for illustration
purposes only. The pattern of pure DSPG shows a coexistence of
orthorhombically and hexagonally packed hydrocarbon chains correspond-
ing to the Lb9 and LbI phases, respectively (dash-dotted lines). A detailed
WAXS data analysis has been presented previously (24). The selected
temperatures are 5C for DMPG, 30C for DPPG, and 45C for DSPG. Data
have been scaled for a better view.
FIGURE 4 NMR order parameter proﬁles (SCD) obtained from deconvo-
luted (de-Paked) 2H-NMR powder spectra of chain-deuterated DPPG (A)
and DSPG (B) in the absence of PGLa (s) and at L/P¼ 100:1 ()) and 25:1
(d). Errors are within the size of the symbols.
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phases for PGs and long-chain PCs in the presence of the
peptides PGLa, melittin, and LL-37 (6,7). Their formation
can be understood assuming that the peptide gets embedded
into the gel phase bilayer at the water/lipid interface, with the
helical axis aligned parallel to the membrane surface. This
creates a void below the peptide, which is compensated for
by moving the methyl termini of the opposing lipid mono-
layer close to the peptide, thereby generating the LbIq phase
(Fig. 8). A compensation of the void by an elastic monolayer
deformation is not possible due to the high bending rigidity
(;100 kBT) in the gel phase (36). The increased acyl chain
disorder observed in DPPG from both WAXS and NMR data
(Figs. 2 and 5) is most likely due to defect zones between the
coexisting gel phases. It is interesting that no such disorder
was observed for DSPG. This indicates that PGLa is more
effective in inducing a LbIq phase due to the larger void in-
duced and the DSPG propensity to form an interdigitated
phase even in the absence of the peptide (24).
In the ﬂuid phase, the bending rigidity of lipid bilayers
is ;1 order of magnitude lower than in the gel phase. Thus,FIGURE 6 Small-angle scattering of DMPG (i), DPPG (ii), and DSPG
(iii) in the ﬂuid phase in the absence and presence of PGLa (L/P ¼ 25:1).
Solid lines show the model ﬁts to the data in the absence of PGLa, and dash-
dotted lines to the data in the presence of PGLa. The selected temperatures
are 30C for DMPG, 45C for DPPG, and 60C for DSPG. Data have been
scaled for a better view.
TABLE 2 Structural parameters of the studied PGs in the














DMPG 30 48.4 6 0.4 14.2 6 0.4 55.1 6 2 1039 6 10 782 6 10
1 PGLa 49.3 6 0.4 14.7 6 0.4 53.3 6 2
DPPG 45 50.2 6 0.4 15.1 6 0.4 61.0 6 2 1178 6 10 921 6 10
1 PGLa 52.2 6 0.4 16.1 6 0.4 57.2 6 2
DSPG 60 52.8 6 0.4 16.4 6 0.4 63.8 6 2 1303 6 10 1046 6 10
1 PGLa 52.5 6 0.4 16.3 6 0.4 64.4 6 2
*When peptide was present, the lipid/peptide ratio was L/P ¼ 25:1.
FIGURE 7 Chain length dependence of the membrane thickness in the Lb9
(squares), LbI (triangles), and La phases (circles). Solid symbols correspond
to the results in the presence of PGLa (L/P ¼ 25:1), and open symbols to
those in the absence of peptide.
FIGURE 8 Schematic representation of PGLa-associated structural
changes in PG bilayers. Below the main phase transition (T , Tm), all
three studied lipids exhibit a quasi-interdigitated phase in the presence of
PGLa. The peptide aligns parallel to the membrane surface and its hydro-
phobic moieties are shielded by the hydrocarbon chains of the opposing lipid
monolayer. In the ﬂuid phase (T . Tm), above a critical threshold concen-
tration, PGLa inserts into the PG membranes and most likely forms toroidal
pores. In DMPG membranes, PGLa inserts at an angle and leads to a small
increase in membrane thickness. The membrane thickening effect is most
pronounced for DPPG membranes, where PGLa inserts vertically into the
bilayer, and least pronounced for DSPG bilayers, in which no membrane
deformation is necessary due to a match of the hydrophobic lipid core with
the hydrophobic peptide length.
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the bilayer may respond elastically to a peptide embedded in
the bilayer interface, leading to a local dimple deformation
(4). Averaged globally over the lipid bilayer, this shows up as
membrane thinning, as previously observed in many x-ray
diffraction studies on lipid/peptide interactions (4,8,37). At
sufﬁciently high concentrations, the peptides may change
their orientation by inserting vertically or at an oblique angle
into the lipid bilayer, forming pores of either barrel stave or
toroidal type. Recent experiments suggest that the process of
pore formation is driven by the entropy of the membrane-
adsorbed peptide ensemble (8). Matching of the hydrophobic
peptide length with the hydrocarbon core of the lipid bilayer
may also lead to a local membrane deformation and thinning
on the global average over the membrane (4). Thus, the ob-
servation of membrane thinning in connection with lipid/
peptide interactions has been hitherto generally taken as
‘‘the’’ ﬁngerprint for pore formation.
It is striking that our x-ray and NMR experiments, in
excellent agreement, show an overall increase of membrane-
order DPPG in the ﬂuid phase (Table 2 and Fig. 4 A). Fur-
thermore, in the case of DSPG, the order-parameter proﬁle
and membrane thickness were not affected at all by PGLa,
even at L/P ¼ 25:1 (Fig. 4 B). This is difﬁcult to reconcile in
terms of the currently accepted views on lipid/peptide inter-
actions. The absence of any effect on DSPG membranes in
the ﬂuid phase could be simply attributed to an expulsion of
the peptide from the bilayer. A possible scenario would be
that the hydrophobic interactions between hydrocarbon
chains, which increase with acyl chain length, ﬁnally over-
rule the electrostatic attraction, rendering the bilayer practi-
cally impenetrable. Indeed, if one compares the area/lipid
values for the three studied PGs in the absence of PGLa
(Table 2) to the reported data for the chain analogous PCs
(DMPC, A ¼ 59.6 A˚2 (38); DPPC, A ¼ 64.0 A˚2 (38); and
DSPC, A ¼ 66.7 A˚2 (39)), one ﬁnds signiﬁcantly smaller
values for the PGs. This signiﬁes increased packing density
for PG bilayers compared to PC membranes, which is un-
expected in view of the negative charges carried by the PG
headgroups. A similar effect was recently reported for
phosphatidylserine bilayers in the absence of salts (40),
which might be due to hydrogen-bond formation, as sug-
gested previously for PG membranes (32). As an alternative,
however, screening of the headgroup charges by the cations
present in the used buffer could also account for this effect. In
any case, the increased molecular packing would seem to
support the above picture of peptide exclusion. However, it is
then difﬁcult to explain why DPPG, whose area/lipid differs
by about the same amount from DPPC as from DSPG and
DSPC, is affected by the peptide and DSPG not. Moreover,
the cooling DSC scans are comparable to the heating scans
(Fig. 1), in particular also for DSPG, showing more or less
identical heat capacity peaks, but being slightly shifted to-
ward lower temperature as a typical hysteresis effect.
Henceforth, PGLa must interact with the DSPG bilayers in
the ﬂuid phase. Thus, we conclude that the peptide is not
dissolved in the aqueous phase, but is somehow in contact
with the lipid bilayer.
An alternative explanation would be that PGLa does not
penetrate into the bilayer in the ﬂuid phase, but lies on its top,
aligning its positive charges with the negative PG headgroup
charges. In fact, Li and Salditt reported an increase of dB in
the presence of magainin 2 for DMPC/DMPG mixtures and
assumed that the peptide leads to a crowding of DMPG due to
electrostatic interactions (37). This is supported by the DPPG
order-parameter proﬁle in the presence of PGLa, showing
that a change in mobility due to a localization of the peptide
in a particular membrane depth is unlikely. Such an effect
might thus explain the observed increase in membrane
thickness for DMPG and DPPG upon the addition of PGLa
(Fig. 7). However, it cannot account for the absence of a
thickening effect in DSPG membranes. The area/lipid of
DSPG bilayers is ;3 A˚2 larger than that of DPPG (Table 2).
Thus, if the PG headgroups were to align with the PGLa
charges, a muchmore pronounced thickening effect would be
expected for DSPG. However, the changes in dB and A in
DSPG bilayers containing PGLa are insigniﬁcant (Table 2).
In addition, PGLa aligned with its polar side toward the
charged membrane surface would require an aggregation of
PGLa to shield its hydrophobic moieties from the aqueous
phase. Such peptide oligomerization would then have to be
reversed upon the transition into the gel phase to form the
quasi-interdigitated phase. This is very unlikely to happen
and we can, therefore, also rule out this explanation.
An indication about the present peptide-bilayer interac-
tions can be obtained considering the length of PGLa and
hydrophobic matching (41) (see also Fig. 8). Assuming a
complete a-helical backbone, the length along its axis turns
out to be;32 A˚ (18,21). This value can now be compared to
2dC for DSPG (Table 2), which remarkably turns out to be
identical. Thus, PGLa would ﬁt perfectly into the hydro-
phobic core of DSPG. Due to this perfect hydrophobic match,
the DSPG bilayers do not need to deform, which explains our
invariant observations from 2H-NMR and x-ray scattering.
The hydrophobic core of DPPG is in turn too small to ac-
commodate the peptide with its full length. It therefore re-
sponds to the insertion of the peptide by stretching of the
hydrocarbon chains, leading to increased order and a larger
membrane thickness. Indeed, an increase of chain order and
membrane thickness has been observed previously for PC
bilayers in the presence of hydrophobic model peptides with
N- and C-terminal anchors (42), and this was also attributed
to hydrophobic matching. It is interesting to note that the dB
of DPPG in the presence of PGLa is about equal to the dB for
DSPG (Table 2). In the case of DMPG, the increase of dB
upon addition of PGLa is, at;1 A˚, signiﬁcantly smaller than
that for DPPG. Apparently, the entropic penalty of increasing
the membrane thickness to a value that can accommodate
PGLa with its helical axis normal to the bilayer surface is too
high. We therefore think that the system responds simply by
tilting the peptide with respect to the DMPG membrane
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normal, requiring only a small increase of membrane thick-
ness as an energetically favorable compromise. In fact, in
support of this argument, PGLa has been shown by solid-
state NMR to insert at an angle of 30 into DMPC/DMPG
bilayers (18), where it has been postulated to be most stable
as an antiparallel dimer maintaining an overall amphiphi-
licity.
In conclusion, we note that this explanation also accounts
for our DSC results, which showed the presence of a peptide-
rich phase that melts/freezes at slightly higher temperature
upon heating and cooling, respectively (Fig. 1). The peptides
simply change their insertion state from being parallel to the
lipid bilayer surface in the gel phase to a transmembrane state
in the ﬂuid phase above a given threshold concentration.
Peptide insertion is probably facilitated by the strong density
ﬂuctuations occurring in the phase transition regime (43,44).
The inserted peptides can be either tilted or not in response to
the elastic properties of the lipid bilayer. Further, we propose
that PGLa, having a net charge of 15, forms pores of the
toroidal type, in agreement with theoretical considerations
(45) and recent experimental observations (19). It is certain
that peptide insertion in the ﬂuid phase occurs only above a
particular threshold concentration, L/P* (21), which was not
determined in this study. However, our 2H-NMR results
suggest that 25 , L/P* , 100 for DPPG, since no effects
could be observed in the order-parameter proﬁle for L/P ¼
100:1 (Fig. 4 A). Recent oriented circular dichroism mea-
surements on PGLa insertion in DMPC bilayers reported a
value in the same concentration range (46).
CONCLUSIONS
Our results on the interaction of the antimicrobial frog-skin
peptide PGLa with PG model membranes unequivocally
demonstrate a complex behavior depending on several pa-
rameters, such as acyl chain length, lipid phase state, and
peptide concentration. Quasi-interdigitated phases were de-
tected for DPPG and DSPG bilayers below the Tm, being
most pronounced for DSPG. This phase is most likely also
present in DMPG bilayers, but difﬁcult to detect at the pres-
ent resolution. In the ﬂuid phase, we observed an increase of
the membrane thickness for DMPG and DPPG, whereas
DSPG bilayers remained unaffected (Fig. 8). It is therefore
not straightforward to extrapolate behavior in the ﬂuid phase
from observations in the gel phase. Furthermore, although
membrane thinning is at present considered the hallmark of
peptide pore formation, it is not a universal response of bi-
layers to insertion of amphipathic peptides. The system may
respond with a tilt of the inserted peptide or an increase of
membrane thickness, or may even remain virtually unper-
turbed, depending on the match of hydrophobic moieties of
lipid and peptide. We believe that this is a general result with
respect to the currently discussed mechanisms of membrane
disruption by AMPs, i.e., the detergentlike carped model and
the formation of discrete barrel stave or toroidal pores (for
recent reviews, see, e.g., (2,47)). Even a detergentlike dis-
integration of lipid membranes proceeds through a transient
insertion of the peptides into the lipid bilayer. This is where
our ﬁndings will apply.
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